About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Music and Adherence Home Programs Post Stroke | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDEARLY Phase 1NCT02906956

Music and Adherence Home Programs Post Stroke

The purpose of this study is to explore whether adherence to upper extremity home programs changes when persons post stroke practice with preferred music.

Lead sponsor: Duquesne University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Duquesne University

Age

40 - 85 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Ages 40-85
•Mild to Moderate hemiparesis as determined by a score of 21 to 50 on the FM- UE
•At least 6 months post stroke
•American English as primary language

Exclusion Criteria

•Significant visual impairment as determined by "aphasia-friendly" and age appropriate screening
•Significant hearing impairment as determined by self-report
•Actively receiving occupational or physical therapy services for upper extremity motor recovery
•Severe auditory comprehension impairment such that they cannot understand one-step directions as indicated by a WAB-R score below 8/10 on Sequential Commands Subtest
•Sitting or standing blood pressure of 180/110 or HE \> 100 bpm

Related studies

Home-based Cognitive Strategy Training for Daily Living in Adults With Chronic Stroke

NCT07084025 · Stroke, Cerebrovascular Disorders

Neurofeedback Intervention for Reading Deficits in Subacute Stroke

NCT04875936 · Stroke, Dyslexia, Acquired

Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke

NCT06292117 · Ischemic Stroke, CYP2C19 Polymorphism

RECRUITINGPhase 2

Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke

NCT05686642 · Acute Ischemic Stroke

Pilot Study on Muscle, Tendon, and Neural Changes Post-Botulinum Toxin Injections in Post-stroke Spastic Equinovarus

NCT06767631 · Stroke, Spasticity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 16, 2019Terms

Trial snapshot

StatusCOMPLETED

PhaseEARLY_PHASE1

Enrollment7

Start dateSep 2016

Last updatedJul 16, 2019

Condition

Locations shown

Duquesne University Speech, Hearing, Language Clinic

Pittsburgh, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 16, 2019Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions